Cargando…
MON-592 Early and More Frequent Monitoring of Thyroid Function Tests (TFTs) Post-RAI Could Be Clinically Beneficial
Background: Radioiodine (RAI) is widely used for the treatment of hyperthyroidism. Most patients respond to RAI therapy with a normalization of TFTs and improvement in clinical symptoms within 4-8 weeks. Hypothyroidism may occur from 4 weeks on, with 40% of patients being hypothyroid by 8 weeks and...
Autores principales: | Aljenaee, Khaled, Ali, Sulaiman, Cooke, Jennie, Phelan, Niamh, Pazderska, Agnieszka, Healy, Marie Louise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550720/ http://dx.doi.org/10.1210/js.2019-MON-592 |
Ejemplares similares
-
MON-590 Outcomes Following Radioactive Iodine Therapy (RAI) in Hyperthyroid Patients with Grave’s Disease and Toxic Nodular Disease
por: Aljenaee, Khaled, et al.
Publicado: (2019) -
SUN-593 Puzzling TFTs: A Case of a TSHoma and Underlying Hashimoto's Disease
por: Blair, Rachel, et al.
Publicado: (2019) -
SAT-592 Amiodarone-Induced Cure Of Graves' Disease
por: Sharma, Eliza, et al.
Publicado: (2019) -
SUN-592 Goiters and Levothyroxine Do Not Always Mix
por: Steven, Scott, et al.
Publicado: (2019) -
SUN-516 Unplanned Pregnancy Post Thyroid RAI Ablation
por: Bhalodkar, Arpita, et al.
Publicado: (2020)